Full Year 2023 Investor Presentation

158 Investor presentation Full year 2023 Barriers to access go beyond price Diabetes Compass launched with World Diabetes Foundation in 2021 Many healthcare systems in LMICs are overburdened Aims to reduce vulnerabilities through innovative digital solutions to support health workers and people with diabetes Pilots in Sri Lanka, Tanzania, and Milawi have been launched to evaluate results and understand the impact of digital solutions Thermal solution for human insulin can address one key access to care barrier Strict insulin storage recommendations are hard to meet in humanitarian settings and where access to refrigeration is low The positive scientific opinion received from EMA in April 2022 supports obtaining the national approvals for additional option for storage outside of refrigeration prior to first use National country approvals in 29 countries iCARE initiative towards strengthening health infrastructure in Middle Africa ⚫ A business-integrated model improving access to treatment and care Capacity: over 3,500 HCPs trained¹ Affordability: 37,400 underserved patients reached with insulin¹ Reach: Expanded partnerships with distributors to reduce mark-ups Empowerment: over 8,000 patients enrolled in patient empowerment programmes¹ DIABETES COMPASS Actrapid ¡CARE 1Values are FY2023 Note: The Diabetes Compass was launched by the World Diabetes Foundation with more information on Diabetes Compass | World diabetes foundation. Diabetes Compass is funded by a 100 million DKK joint donation from Novo Nordisk A/S and the Novo Nordisk Foundation. HCP: Health care professional; LMIC: Low- and middle-incomes countries. Novo NordiskⓇ

View entire presentation